TGFB1 and breast cancer: An immunosuppressive microenvironment exemplified by a rewired cytokine network and upregulated immune checkpoint proteins is a hallmark of advanced and therapy-refractory tumors.40 Here, we found that trastuzumab increased the production of TGF-β and IFN-γ by breast cancer cells and NK cells, respectively.